Clinical Trial Comparing Gemcitabine and Vandetanib Therapy With Gemcitabine Alone in Pancreatic Carcinoma (ViP)
This study is currently recruiting participants.
Verified May 2012 by University of Liverpool
Sponsor:
University of Liverpool
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Dr Gary MIddleton, University of Liverpool
ClinicalTrials.gov Identifier:
NCT01601808
First received: February 22, 2012
Last updated: May 16, 2012
Last verified: May 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | October 2013 |
| Estimated Primary Completion Date: | October 2012 (Final data collection date for primary outcome measure) |